Key result
Ultrasound renal denervation cuts daytime ambulatory SBP by ~8 mmHg vs sham at 2 months.
Why the study?
The relationship between plasma renin and aldosterone concentrations and the blood pressure response to endovascular ultrasound renal denervation was uncertain.
RCT (n=53)
Sham-controlled
Randomized
Answers are grounded in this paper and cite their sources.
Baseline renin and aldosterone levels should not guide renal denervation selection; leaves open identification of reliable response predictors.
OBJECTIVE: The RADIANCE-HTN SOLO trial demonstrated a greater reduction in daytime ambulatory SBP at 2 months by endovascular ultrasound renal denervation than sham procedure. We hypothesized that plasma renin and aldosterone concentrations would be associated with the SBP response to renal denervation. METHODS: Hypertensive patients were randomized to renal denervation (n = 74) or sham (n = 72) after a 4-week washout of antihypertensive medications. In a 53-patient subset, 2-month and 6-month plasma renin and aldosterone concentration were measured. Dietary sodium was not controlled. RESULTS: Mean age of the 29 treatment and 24 sham patients was 54 years; 62% were men; 17% black. Daytime ambulatory SBP fell in the denervation but not the sham group at 2 months (-7.8 ± 10.7 vs. -0.1 ± 10.1 mmHg; P = 0.048). Baseline plasma renin and aldosterone concentrations were in the low-normal range, did not change significantly at 2 months in either group and did not predict response to renal denervation. At 6 months, after the addition of antihypertensive medications, there was a significant rise in renin in the sham but not the denervation group. CONCLUSION: Although renal denervation but not sham resulted in a decrease in daytime ambulatory SBP at 2 months, renin and aldosterone concentrations did neither predict the BP response to renal denervation; nor did they fall after denervation. A rise in renin at 6 months in the sham group likely represents confounding from antihypertensive medications. Whether the BP-lowering effect of renal denervation depends on reducing local intrarenal renin release requires further study.
No takes yet. Share an insight, caveat, or question.
Lobo et al. (2021) conducted an RCT in Hypertension (n=53). Endovascular ultrasound renal denervation vs. Sham procedure was evaluated on Change in daytime ambulatory systolic blood pressure at 2 months (p=0.048). Endovascular ultrasound renal denervation reduced daytime ambulatory systolic blood pressure at 2 months compared to sham, but baseline renin and aldosterone levels did not predict this response.
Synapse has enriched 10 related papers. Consider them for comparative context: